These data suggest that IL-4 administration post-MI enabled to strengthen the intrinsic myocardial-repair system, in which cardiac M2-like macrophages play a role, highlighting a potential of IL-4 as a promising biological drug for the treatment of MI. This evidence concerns the gene IL4 and myocardial infarction.